{"id":221195,"title":"Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T17:13:16.413000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/draft-guidance-industry-preparation-quality-information-radiopharmaceuticals.html?wbdisable=true","snippet":"Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document - Canada.ca Skip to main content Skip to \"About…","rawSnapshotUrl":"/api/snapshots/raw/221195","browseUrl":"https://replay.healtharchive.ca/job-1/20250418171316/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/draft-guidance-industry-preparation-quality-information-radiopharmaceuticals.html?wbdisable=true#ha_snapshot=221195","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}